ISSN: 1309 - 3843 E-ISSN: 1307 - 7384
FİZİKSEL TIP VE REHABİLİTASYON
BİLİMLERİ DERGİSİ
www.jpmrs.com
Kayıtlı İndexler
ORIJINAL ARAŞTIRMA
Geriatrik Kadınlarda Osteosarkopenik Obezite ile Kırılganlık, Denge, El Kavrama Kuvveti, Yorgunluk, Depresyon ve Yaşam Kalitesi Arasındaki İlişki
The Relationship Between Osteosarcopenic Obesity with Frailty, Balance, Hand Grip Strength, Fatigue, Depression and Quality of Life in Geriatric Women
Received Date : 18 Oct 2020
Accepted Date : 27 Feb 2021
Available Online : 12 Mar 2021
Özet PDF Benzer Makaleler
Elif Umay ALTAŞa, Korhan Barış BAYRAMb
aDepartment of Physical Medicine and Rehabilitation, İzmir Bakırçay University Çiğli Training and Research Hospital, İzmir, TURKEY bDepartment of Physical Medicine and Rehabilitation, İzmir Kâtip Çelebi University Atatürk Training and Research Hospital, İzmir, TURKEY
Doi: 10.31609/jpmrs.2020-79633 - Makale Dili: EN
J PMR Sci. 2021;24(2):127-34
ÖZET
Amaç: Bu çalışmanın amacı, osteosarkopenik obezitenin (OSO) geriatrik popülasyonda kırılganlık, denge, yorgunluk, depresyon ve yaşam kalitesiyle ilişkisinin araştırılmasıdır. Gereç ve yöntemler: Kesitsel olarak tasarlanan çalışmaya, beden kitle indeksi (BKİ) >30 kg/m2 olup çift enerjili X ışını absorbsiyometrisi ve kas gücü ölçümleri sonrası OSO tanısı alan, 65 yaş üzerinde 40 kadın hasta dâhil edildi. Hastaların demografik özellikleri kayıt altına alınıp kırılganlık, kas gücü, mobilite, denge, yorgunluk, depresyon ve yaşam kalitesi parametreleri anketlerle değerlendirildi. Bulgular: Çalışmaya alınan 40 kadın hastanın yaş ortalaması 70,72±5,27, BKİ ortalaması ise 35,51±4,83 idi. Vücut yağ yüzdesi ortalama 48,48±4,84, Edmonton Kırılganlık Ölçeği puan ortalaması da 7,40±3,33’tü. Hiçbir klinik parametre ile BKİ arasında anlamlı korelasyon saptanmadı. Hastaların vücut yağ yüzdeleri ile kırılganlık, yorgunluk ve depresyon arasında pozitif yönde (r=0,813, r=0,792, r=0,538), yağ yüzdesi ile kas gücü ve denge arasında negatif yönde (r=-0,420, r=-0,771) istatistiksel olarak anlamlı korelasyon saptandı. Sonuç: Geriatrik popülasyonda OSO tanılı hastalarda kırılganlık, yorgunluk ve depresyon düzeyinin arttığı, dengenin ve yaşam kalitesinin bozulduğu gösterildi. Ayrıca OSO tanısında BKİ’nin tek başına anlamlı olmadığı, yağ yüzde oranının klinik parametreler üzerine daha anlamlı olduğu belirtildi. Özellikle geriatrik popülasyonda OSO ile ilgili farkındalık yaratmak, sağlıklı yaşlanma için atılacak önemli bir adımdır.
Anahtar Kelimeler: Osteosarkopenik obezite; kırılganlık; yorgunluk; depresyon
ABSTRACT
Objective: The aim of this study is to investigate the relationship between osteosarcopenic obesity (OSO) with frailty, balance, fatigue, depression and quality of life in the geriatric population. Material and Methods: Forty female patients who were over 65 years of age, had a body mass index (BMI) >30 kg/m2 and were diagnosed with OSO after dual-energy X-ray absorptiometry and muscle strength measurements were included in the cross-sectional study. The demographic characteristics of the patients were recorded, and the parameters of frailty, muscle strength, mobility, balance, fatigue, depression and quality of life were evaluated with questionnaires. Results: The mean age of the 40 female patients included in the study was 70.72±5.27, and the mean BMI was 35.51±4.83. They had a mean body fat percentage of 48.48±4.84 and an Edmonton Frailty Scale score of 7.40±3.33. No significant correlation was detected between BMI and any of the clinical parameters. A significant and positive correlation was observed between patients’ body fat percentages and frailty, fatigue and depression (r=0.813, r=0.792, r=0.538), while a significant and negative correlation was detected between fat percentage and muscle strength and balance (r=-0.420, r=-0.771). Conclusion: Our findings demonstrate that the level of frailty, fatigue, and depression increased, and balance and quality of life were impaired in geriatric patients diagnosed with OSO. In addition, we found that BMI alone was not a significant parameter in the diagnosis of OSO, while the fat percentage was more significant on the clinical parameters. Raising awareness about OSO in the geriatric population is an important step towards healthy aging.
Keywords: Osteosarcopenic obesity; frailty; fatigue; depression
REFERENCES
  1. Ilich JZ, Kelly OJ, Inglis JE, et al. Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev. 2014;15:51-60. [Crossref]  [PubMed] 
  2. Stenholm S, Harris TB, Rantanen T, et al. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11:693-700. [Crossref]  [PubMed]  [PMC] 
  3. JafariNasabian P, Inglis JE, Kelly OJ, et al. Osteosarcopenic obesity in women: impact, prevalence, and management challenges. Int J Womens Health. 2017;13;9:33-42. [Crossref]  [PubMed]  [PMC] 
  4. Ilich JZ, Kelly OJ, Kim Y, et al. Low-grade chronic inflammation perpetuated by modern diet as a promoter of obesity and osteoporosis. Arh Hig Rada Toksikol. 2014;65:139-48. [Crossref]  [PubMed] 
  5. Zhao LJ, Jiang H, Papasian CJ, et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 2008;23:17-29. [Crossref]  [PubMed]  [PMC] 
  6. Jafarinasabian P, Chi YC, Ilich J. Adipokines as mediators of bone density in overweight/obese postmenopausal women after 6-month weight loss program. FASEB J. 2015;29:738.4. [Link] 
  7. Hamrick MW, McGee-Lawrence ME, Frechette DM. Fatty infiltration of skeletal muscle: mechanisms and comparisons with bone marrow adiposity. Front Endocrinol (Lausanne). 2016;20;7:69. [Crossref]  [PubMed]  [PMC] 
  8. NIH Consensus Development Program [Internet]. [Cited: 29.12.2016]. Retirement of the National Institutes of health consensus development program. Available from: [Link] 
  9. Ormsbee MJ, Prado CM, Ilich JZ, et al. Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle. 2014;5:183-92. [Crossref]  [PubMed]  [PMC] 
  10. Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136. [Crossref]  [PubMed]  [PMC] 
  11. Shin H, Liu PY, Panton LB, et al. Physical performance in relation to body composition and bone mineral density in healthy, overweight, and obese postmenopausal women. J Geriatr Phys Ther. 2014;37:7-16. [Crossref]  [PubMed] 
  12. Ace FitAce Fitness [Internet]. © 2016 The American Council on Exercise. [Cited: 01.01.2016]. What are the guidelines for percentage of body fat loss? Available from: [Link] 
  13. Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 20191;48:16-31. Erratum in: Age Ageing. 2019;1;48:601. [PubMed]  [PMC] 
  14. Rolfson DB, Majumdar SR, Tsuyuki RT, et al. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35:526-9. [Crossref]  [PubMed]  [PMC] 
  15. Aygör HE, Fadıloğlu Ç, Şahin S, et al. Validation of edmonton frail scale into elderly Turkish population. Arch Gerontol Geriatr. 2018;76:133-7. [Crossref]  [PubMed] 
  16. Haidar SG, Kumar D, Bassi RS, et al. Average versus maximum grip strength: which is more consistent? J Hand Surg Br. 2004;29:82-4. [Crossref]  [PubMed] 
  17. Bischoff HA, Stähelin HB, Monsch AU, et al. Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women. Age Ageing. 2003;32:315-20. [Crossref]  [PubMed] 
  18. Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc. 1986;34:119-26. [Crossref]  [PubMed] 
  19. Krupp LB, LaRocca NG, Muir J, et al. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990;17:1450-2. [PubMed] 
  20. Gencay-Can A, Can SS. Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia. Rheumatol Int. 2012;32:27-31. [Crossref]  [PubMed] 
  21. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982-1983;17:37-49. [Crossref]  [PubMed] 
  22. Ertan T, Eker E. Reliability, validity, and factor structure of the geriatric depression scale in Turkish elderly: are there different factor structures for different cultures? Int Psychogeriatr. 2000;12:163-72. [Crossref]  [PubMed] 
  23. McKenna SP, Hunt SM, McEwen J. Weighting the seriousness of perceived health problems using Thurstone's method of paired comparisons. Int J Epidemiol. 1981;10:93-7. [Crossref]  [PubMed] 
  24. Kücükdeveci AA, McKenna SP, Kutlay S, et al. The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res. 2000;23:31-8. [Crossref]  [PubMed] 
  25. Ilich JZ, Inglis JE, Kelly OJ, et al. Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women. Osteoporos Int. 2015;26:2587-95. [Crossref]  [PubMed] 
  26. Gajic-Veljanoski O, Papaioannou A, Kennedy C, et al; CaMos Research Group. Osteoporotic fractures and obesity affect frailty progression: a longitudinal analysis of the Canadian multicentre osteoporosis study. BMC Geriatr 2018;18:4. [Crossref]  [PubMed]  [PMC] 
  27. Dawson A, Dennison E. Measuring the musculoskeletal aging phenotype. Maturitas. 2016;93:13-7. [Crossref]  [PubMed]  [PMC] 
  28. Choi KM. Sarcopenia and sarcopenic obesity. Korean J Intern Med. 2016;31:1054-60. [Crossref]  [PubMed]  [PMC] 
  29. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415-45. [Crossref]  [PubMed] 
  30. Öztürk ZA, Türkbeyler İH, Abiyev A, et al. Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity. Intern Med J. 2018;48:973-81. [Crossref]  [PubMed] 
  31. Huo YR, Suriyaarachchi P, Gomez F, et al. Phenotype of sarcopenic obesity in older individuals with a history of falling. Arch Gerontol Geriatr. 2016;65:255-9. [Crossref]  [PubMed] 
  32. Hubert B, Miot S, Bernard PL. How can we prevent falls? In: Falaschi P, Marsh D, eds. Orthogeriatrics: The Management of Older Patients with Fragility Fractures. Cham (CH): Springer; 2021. (Baskı sayısı eklenmelidir.) [Link] 
  33. Sànchez-Riera L, Carnahan E, Vos T, et al. The global burden attributable to low bone mineral density. Ann Rheum Dis. 2014;73:1635-45. [Crossref]  [PubMed] 
  34. Lang T, Cauley JA, Tylavsky F, et al; Health ABC Study. Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J Bone Miner Res. 2010;25:513-9. [Crossref]  [PubMed]  [PMC] 
  35. De Laet C, Kanis JA, Odén A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330-8. [Crossref]  [PubMed] 
  36. Theou O, Jones GR, Jakobi JM, et al.. A comparison of the relationship of 14 performance-based measures with frailty in older women. Appl Physiol Nutr Metab. 2011;36:928-38. [Crossref]  [PubMed] 
  37. Ma Y, Zhang W, Han P, et al. Osteosarcopenic obesity associated with poor physical performance in the elderly chinese community. Clin Interv Aging. 2020;11;15:1343-52. [Crossref]  [PubMed]  [PMC] 
  38. Szlejf C, Parra-Rodríguez L, Rosas-Carrasco O. Osteosarcopenic obesity: prevalence and relation with frailty and physical performance in middle-aged and older women. J Am Med Dir Assoc. 2017;1;18:733.e1-e5. [Crossref]  [PubMed] 
  39. Patino-Hernandez D, David-Pardo DG, Borda MG, et al. Association of fatigue with sarcopenia and its elements: a secondary analysis of SABE-Bogotá. Gerontol Geriatr Med. 2017;10;3:2333721417703734. [Crossref]  [PubMed]  [PMC] 
  40. Vlietstra L, Stebbings S, Meredith-Jones K, et al. Sarcopenia in osteoarthritis and rheumatoid arthritis: the association with self-reported fatigue, physical function and obesity. PLoS One. 2019;6;14:e0217462. [Crossref]  [PubMed]  [PMC] 
  41. Hamer M, Batty GD, Kivimaki M. Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English longitudinal study of ageing. Int J Obes (Lond). 2015;39:1717-20. [Crossref]  [PubMed]  [PMC] 
  42. Lino VTS, Rodrigues NCP, O'Dwyer G, et al. Handgrip strength and factors associated in poor elderly assisted at a primary care unit in Rio de Janeiro, Brazil. PLoS One. 2016;11:e0166373. [Crossref]  [PubMed]  [PMC] 
  43. Olgun Yazar H, Yazar T. Prevalence of sarcopenia in patients with geriatric depression diagnosis. Ir J Med Sci. 2019;188:931-8. [Crossref]  [PubMed] 
  44. Ishii S, Chang C, Tanaka T, et al. The association between sarcopenic obesity and depressive symptoms in older Japanese adults. PLoS One. 2016;14;11:e0162898. [Crossref]  [PubMed]  [PMC] 
  45. Ul-Haq Z, Mackay DF, Fenwick E, Pell JP. Association between body mass index and mental health among Scottish adult population: a cross-sectional study of 37,272 participants. Psychol Med. 2014;44:2231-40. [Crossref]  [PubMed] 
  46. Keramidaki K, Tsagari A, Hiona M, et al. Osteosarcopenic obesity, the coexistence of osteoporosis, sarcopenia and obesity and consequences in the quality of life in older adults ≥65 years-old in Greece. J Frailty Sarcopenia Falls. 2019;1;4:91-101. [Crossref]  [PubMed]  [PMC] 
  47. Medical Advisory Secretariat. Prevention of falls and fall-related injuries in community-dwelling seniors: an evidence-based analysis. Ont Health Technol Assess Ser. 2008;8:1-78. [PubMed]  [PMC] 
Copyright © 2024
Bu sitenin tüm hakları Türkiye Fiziksel Tıp ve Rehabilitasyon Uzman Hekimleri Derneği'ne aittir.
Site Tasarım ve Yönetim: Türkiye Klinikleri